Mindfunlness Meditation for Type 2 Diabetes

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Type 2 Diabetes+2 MoreMindfunlness Meditation - Behavioral
Eligibility
21 - 75
All Sexes
What conditions do you have?
Select

Study Summary

This trial will study whether a mindfulness meditation program can help African-American adults with type 2 diabetes improve their sleep and reduce stress, which may in turn reduce their risk of cardiovascular disease.

Eligible Conditions
  • Type 2 Diabetes
  • Stress
  • Sleep

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

4 Primary · 3 Secondary · Reporting Duration: Change from baseline at 8 weeks

Week 16
Inflammatory Markers
Sleep Disturbances
Sleep Impairment
Week 16
Perceived Stress
Sleep Quality
Week 8
Cardiovascular Risk
Week 8
Hemoglobin A1c

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Usual Care
1 of 2
Mindfulness Meditation Classes
1 of 2

Active Control

Experimental Treatment

100 Total Participants · 2 Treatment Groups

Primary Treatment: Mindfunlness Meditation · No Placebo Group · N/A

Mindfulness Meditation Classes
Behavioral
Experimental Group · 1 Intervention: Mindfunlness Meditation · Intervention Types: Behavioral
Usual CareNoIntervention Group · 1 Intervention: Usual Care · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: change from baseline at 8 weeks

Who is running the clinical trial?

National Heart, Lung, and Blood Institute (NHLBI)NIH
3,588 Previous Clinical Trials
46,945,602 Total Patients Enrolled
University of Illinois at ChicagoLead Sponsor
538 Previous Clinical Trials
1,551,239 Total Patients Enrolled
Alana BiggersPrincipal InvestigatorUniversity of Illinois at Chicago

Eligibility Criteria

Age 21 - 75 · All Participants · 7 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have type 2 diabetes.
You have a mobile device that can connect to the internet if you are at least 18 years of age.